2 Recession-Resistant Dividend Stocks to Buy Now

Core Viewpoint - The article discusses the potential resilience of CVS Health and Gilead Sciences during economic downturns, suggesting they are solid investments even in uncertain economic conditions [1]. Group 1: CVS Health - CVS Health operates over 9,000 locations in the U.S. and has established strong community relationships, which may help it navigate economic challenges [2]. - The company has faced challenges in its Medicare Advantage business but is focusing on profitable growth by scaling back this segment, which should improve margins and financial results [3]. - CVS Health offers an attractive dividend yield of 3.4%, significantly higher than the S&P 500's 1.2%, and has increased its dividend by 56.5% over the past decade, making it a solid choice for recession-resistant investment [3]. Group 2: Gilead Sciences - Gilead Sciences is a leading biotech company known for its strong portfolio in the HIV market, including key products like Biktarvy and Descovy, and has expanded into oncology and COVID-19 treatments [4]. - The company's HIV products are essential for patients, which should help maintain sales even during a recession, despite recent fluctuations in revenue from Veklury [5]. - Gilead has a robust pipeline in oncology that is expected to support future product launches and sales growth, positioning the company well for economic challenges [5].